Welcome to our dedicated page for Adtalem Global Education Common Shares news (Ticker: $ATGE), a resource for investors and traders seeking the latest updates and insights on Adtalem Global Education Common Shares stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Adtalem Global Education Common Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Adtalem Global Education Common Shares's position in the market.
Adtalem Global Education Inc. (NYSE: ATGE) reported strong fiscal third quarter 2024 results with revenue up 11.8% YoY, total enrollment up 7.8% YoY, and adjusted EPS growth of 32.7% YoY. The company's strategic focus on Growth with Purpose led to accelerated enrollment growth, enhanced profitability, and robust financial performance. Adtalem's subsidiaries achieved high residency attainment rates, expanded nursing education programs, and increased student enrollment. The company raised its fiscal year 2024 revenue guidance to $1,560 million to $1,580 million and adjusted EPS to $4.80 to $5.00.